Michael Gossop focuses on Psychiatry, Heroin, Addiction, Substance abuse and Methadone. His Psychiatry research incorporates elements of Structured interview, Prospective cohort study and Injury prevention. His Heroin research includes elements of Cocaine users, Treatment outcome, Demography and Abstinence.
His Addiction research is multidisciplinary, incorporating perspectives in Narcotic antagonist, Help-seeking and Follow up studies. The various areas that Michael Gossop examines in his Substance abuse study include Drug withdrawal, Social environment and Psychometrics, Clinical psychology. His studies in Methadone integrate themes in fields like Buprenorphine, Clinical trial and MEDLINE.
His primary areas of investigation include Psychiatry, Heroin, Addiction, Methadone and Drug. His Psychiatry study combines topics from a wide range of disciplines, such as Public health, Treatment outcome and Clinical psychology. The Heroin study combines topics in areas such as Structured interview and Cohort.
His studies deal with areas such as Buprenorphine and Prospective cohort study, Internal medicine as well as Methadone. His work deals with themes such as Naloxone, Randomized controlled trial and Naltrexone, which intersect with Anesthesia.
The scientist’s investigation covers issues in Psychiatry, Heroin, Methadone, Anesthesia and Internal medicine. His Psychiatry research includes themes of Treatment outcome, Opioid maintenance treatment and Cohort. He has researched Heroin in several fields, including Drug dependent, Emergency medicine, Drug overdose, Clinical psychology and Addiction.
His Addiction research is multidisciplinary, relying on both Logistic regression and Drug. His research integrates issues of MEDLINE, Intervention, Randomized controlled trial, Buprenorphine and Health psychology in his study of Methadone. His work in Anesthesia addresses subjects such as Naltrexone, which are connected to disciplines such as Pharmacology and Implant.
His scientific interests lie mostly in Psychiatry, Heroin, Methadone, Anesthesia and Naltrexone. His Psychiatry research incorporates elements of Public health, Treatment outcome and Cohort. His studies deal with areas such as Reliability, Validity, Scale and Emergency medicine as well as Heroin.
His Methadone research includes themes of Buprenorphine, Internal medicine, Randomized controlled trial and MEDLINE. Michael Gossop focuses mostly in the field of Anesthesia, narrowing it down to matters related to Implant and, in some cases, Pharmacotherapy, Narcotic antagonist, Drug and Treatment options. Michael Gossop has included themes like Addiction and Pharmacology in his Naltrexone study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users.
Michael Gossop;Shane Darke;Paul Griffiths;Julie Hando.
Addiction (1995)
The Maudsley Addiction Profile (MAP):A brief instrument for assessing treatment outcome.
John Marsden;Michael Gossop;Duncan Stewart;David Best.
Addiction (1998)
The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results.
Michael Gossop;John Marsden;Duncan Stewart;Tara Kidd.
Addiction (2003)
Fortnightly Review: Methadone maintenance treatment in opiate dependence: a review
M Farrell;J Ward;R Mattick;W Hall.
BMJ (1994)
Reaching hidden populations of drug users by privileged access interviewers: methodological and practical issues
Peter Griffiths;Michael Gossop;B Powis;John Strang.
Addiction (1993)
A prospective study of mortality among drug misusers during a 4-year period after seeking treatment
Michael Gossop;Duncan Stewart;Samantha Treacy;John Marsden.
Addiction (2002)
Severity of dependence and route of administration of heroin, cocaine and amphetamines
Michael Gossop;Paul Griffiths;Beverly Powis;John Strang.
Addiction (1992)
Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: Protective effect of coping responses.
Michael Gossop;Duncan Stewart;Nadine Browne;John Marsden.
Addiction (2002)
Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study
John Strang;Jim McCambridge;David Best;Tracy Beswick.
BMJ (2003)
The development of a Short Opiate Withdrawal Scale (SOWS)
Michael Gossop.
Addictive Behaviors (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
King's College London
King's College London
University of Derby
University of New South Wales
University of Southampton
University of Queensland
Griffith University
King's College London
University of Toronto
London School of Economics and Political Science
University of Southern California
Arizona State University
United States Air Force Research Laboratory
University of Illinois at Chicago
University of Illinois at Urbana-Champaign
Veterans Health Administration
Loughborough University
University of York
London School of Hygiene & Tropical Medicine
Cornell University
University of Otago
Seoul National University
Utrecht University
University of Bergen
University of Konstanz